Skip to content

Implementing recommendations for Polypharmacotherapy of multimorbid Patients (PomP)

A tailored implementation intervention to implement recommendations addressing Polypharmacotherapy of multimorbid Patients (PomP): study protocol of a cluster-randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN34664024
Enrollment
1000
Registered
2013-08-14
Start date
2013-11-01
Completion date
Unknown
Last updated
2017-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Implementation of recommendations for polypharmacotherapy in multimorbid patients Not Applicable

Interventions

Practice teams (1 general practitioner, 1 health care assistant per practice) will participate in a workshop about polypharmacotherapy. The practice teams will create an individual concept which descr

Sponsors

European Union (Netherlands)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: For general practitioners: 1. Enrolment in a general practice centred care contract (HZV AOK Baden-Wuerttemberg) 2. Continuous attendance in a specific quality circle every three months in the previous 12 months For patients: 1. Aged over 64 years 2. Enrolment in general practice-centred care contract (HZV AOK Baden-Wuerttemberg) 3. Repeated prescriptions of more than four drugs in one quarter of the year 4. Being diagnosed with at least three chronic conditions 5. Especially in need for intensified medication management (according to the personal assessment of the general practitioner, e.g. non-adherence, hospitalisation due to medication related events).

Exclusion criteria

Exclusion criteria: 1. For physicians: Physicians having participated in another study focusing on multimorbidity or polypharmacotherapy in the last year are excluded 2. For patients: Lacking ability or need for intensified medication management according to the personal assessment of the general practitioner.

Design outcomes

Primary

MeasureTime frame
The degree of implementation of the three recommendations measured at patient level. The degree of implementation will be expressed by the number of indicators fulfilled per patient included in the study.

Secondary

MeasureTime frame
A comprehensive process evaluation will be performed including questionnaires for intervention fidelity and measures to evaluate the tailoring strategy.

Countries

Germany

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 22, 2026